Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.

Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.

Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.

再生医学可替换或再生人体细胞、组织或器官，以恢复或建立正常功能*。自 2006 年以来，《再生医学》一直处于出版涵盖整个再生医学领域的最佳论文和评论的前沿。该期刊专注于再生医学的整个方法范围，包括小分子药物、生物制剂、生物材料和组织工程以及细胞和基因疗法 - 一切都与再生有关，而不是特定的平台技术。该期刊的范围涵盖该领域的所有方面，从发现研究到临床开发再到商业化。 《再生医学》通过提供一本完全致力于发表最优秀再生医学研究、临床转化和商业化的同行评审期刊，为生物医学和医疗保健这一重要领域提供了独特的支持。

《再生医学》提供了一个专业论坛来应对再生医学的重要挑战和进步，以简洁、清晰和有吸引力的文章格式提供这些基本信息——这对于快速发展、多学科和时间越来越紧迫的社区至关重要。

尽管我们对再生的知识和理解有了实质性的发展，但该领域仍处于起步阶段。然而，进展正在加速。未来几十年，我们将发现和开发针对患者的变革性疗法，在某些情况下，甚至是治愈方法。随着这些进展的进展、临床试验，并最终成为主流医学，《再生医学》将继续对这些进展进行批判性概述。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-工程：生物医学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为2.4，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。